NUP210
Basic information
Region (hg38): 3:13316235-13420322
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUP210 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 125 | 18 | 145 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 125 | 24 | 5 |
Variants in NUP210
This is a list of pathogenic ClinVar variants found in the NUP210 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-13316486-A-G | Benign (Apr 29, 2020) | |||
3-13317697-G-T | not specified | Uncertain significance (Apr 18, 2024) | ||
3-13317721-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
3-13317754-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
3-13317769-G-A | not specified | Uncertain significance (May 16, 2023) | ||
3-13319092-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
3-13319116-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
3-13319131-C-T | not specified | Conflicting classifications of pathogenicity (Sep 26, 2023) | ||
3-13319244-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
3-13319271-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
3-13319781-G-A | not specified | Uncertain significance (Mar 23, 2022) | ||
3-13319940-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
3-13319946-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
3-13321602-C-T | NUP210-related disorder | Likely benign (Jul 28, 2022) | ||
3-13321607-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
3-13321672-G-A | Benign (Jul 10, 2018) | |||
3-13321707-C-G | not specified | Uncertain significance (Apr 29, 2024) | ||
3-13321736-G-C | not specified | Uncertain significance (Mar 13, 2023) | ||
3-13321787-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
3-13321818-T-C | not specified | Likely benign (Mar 29, 2023) | ||
3-13321821-A-C | not specified | Uncertain significance (Jun 28, 2022) | ||
3-13322283-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
3-13322315-T-C | not specified | Uncertain significance (Jan 02, 2024) | ||
3-13323393-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
3-13325815-G-A | not specified | Uncertain significance (Dec 03, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NUP210 | protein_coding | protein_coding | ENST00000254508 | 40 | 104073 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.10e-22 | 1.00 | 125564 | 1 | 183 | 125748 | 0.000732 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.782 | 1070 | 1.14e+3 | 0.935 | 0.0000710 | 12161 |
Missense in Polyphen | 176 | 222.94 | 0.78945 | 2447 | ||
Synonymous | -0.955 | 532 | 505 | 1.05 | 0.0000361 | 3966 |
Loss of Function | 3.66 | 50 | 86.8 | 0.576 | 0.00000431 | 945 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00126 | 0.00126 |
Ashkenazi Jewish | 0.000803 | 0.000794 |
East Asian | 0.000441 | 0.000381 |
Finnish | 0.0000475 | 0.0000462 |
European (Non-Finnish) | 0.000761 | 0.000756 |
Middle Eastern | 0.000441 | 0.000381 |
South Asian | 0.00138 | 0.00134 |
Other | 0.00148 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Nucleoporin essential for nuclear pore assembly and fusion, nuclear pore spacing, as well as structural integrity. {ECO:0000269|PubMed:14517331}.;
- Pathway
- RNA transport - Homo sapiens (human);tRNA processing;Disease;Gene expression (Transcription);sumoylation by ranbp2 regulates transcriptional repression;cycling of ran in nucleocytoplasmic transport;Regulation of HSF1-mediated heat shock response;Metabolism of carbohydrates;Rev-mediated nuclear export of HIV RNA;Late Phase of HIV Life Cycle;HIV Life Cycle;Interactions of Rev with host cellular proteins;Host Interactions of HIV factors;HIV Infection;snRNP Assembly;Vpr-mediated nuclear import of PICs;SUMOylation of DNA damage response and repair proteins;Transport of Ribonucleoproteins into the Host Nucleus;Viral Messenger RNA Synthesis;Export of Viral Ribonucleoproteins from Nucleus;SUMOylation of chromatin organization proteins;Influenza Viral RNA Transcription and Replication;Cellular responses to stress;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMOylation of DNA replication proteins;SUMO E3 ligases SUMOylate target proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Metabolism of proteins;Influenza Life Cycle;Influenza Infection;Metabolism of RNA;Glycolysis and Gluconeogenesis;Infectious disease;Leukotriene metabolism;Squalene and cholesterol biosynthesis;Purine metabolism;Vitamin B3 (nicotinate and nicotinamide) metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Pyrimidine metabolism;SUMOylation;Glycosphingolipid metabolism;Cellular responses to external stimuli;Regulation of Glucokinase by Glucokinase Regulatory Protein;Glycolysis;Phosphatidylinositol phosphate metabolism;Lysine metabolism;Methionine and cysteine metabolism;Selenoamino acid metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Aminosugars metabolism;Pentose phosphate pathway;Nuclear Pore Complex (NPC) Disassembly;De novo fatty acid biosynthesis;Glycerophospholipid metabolism;Prostaglandin formation from dihomo gama-linoleic acid;Putative anti-Inflammatory metabolites formation from EPA;Vitamin D3 (cholecalciferol) metabolism;Vitamin E metabolism;tRNA processing in the nucleus;Transport of Mature mRNA derived from an Intron-Containing Transcript;mechanism of protein import into the nucleus;Signaling events mediated by HDAC Class II;Metabolism of non-coding RNA;Cellular response to heat stress;Nuclear Envelope Breakdown;Mitotic Prophase;M Phase;Nuclear import of Rev protein;Glucose metabolism;Transcriptional regulation by small RNAs;Cell Cycle;Interactions of Vpr with host cellular proteins;Glycine, serine, alanine and threonine metabolism;Cell Cycle, Mitotic;Sumoylation by RanBP2 regulates transcriptional repression;Transport of Mature Transcript to Cytoplasm;Signaling events mediated by HDAC Class I;Processing of Capped Intron-Containing Pre-mRNA;Arachidonic acid metabolism;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.793
- rvis_EVS
- -2.01
- rvis_percentile_EVS
- 1.72
Haploinsufficiency Scores
- pHI
- 0.167
- hipred
- N
- hipred_score
- 0.481
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.785
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nup210
- Phenotype
Zebrafish Information Network
- Gene name
- nup210
- Affected structure
- muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- undulate
Gene ontology
- Biological process
- mRNA export from nucleus;viral process
- Cellular component
- nuclear envelope;nuclear pore;endoplasmic reticulum membrane;membrane;integral component of membrane;nuclear membrane
- Molecular function
- protein dimerization activity